Table 1.
Case N. | Age | Menopause | FIGO | TMN | Size cm. | Mitosis/10HPF | Necrosis | MHC Class I | MHC Dynamics | Desmin | B7H3 | Axl | IDO | Total cells/sq mm | Segmented/total DAPI | Predominant T cell phenotype |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 39 | No | IVB | pT3aNxM1 | 6 | 20 | Present | +++ | induced | + | + het | ++ | pos | 900 | 31% | Tex-chronic |
2 | 63 | Yes | IVB | pT1bNxM1 | 16 | 11 | Present | +++ | constitutive | + | + | ± | pos weak | 1248 | 23% | Tex-acute |
3 | 34 | No | N/A | N/A | 2 | 9 | Absent | + | induced | +++ | + het | ++ | pos | 517 | 15% | Deserted |
4 | 36 | No | IB | pT1bN0Mx | 11 | 50 | Present | ± | constitutive | ± | +++ | ++ | pos | 210 | 5% | Deserted |
5 | 55 | Yes | IIIB | pT3bNxMx | 20 | 18 | Absent | + | induced | neg | +++ | ++ het | pos | 2567 | 77% | Tex-acute |
6 | 61 | Yes | IB | pT1bNxMx | 12 | 25 | Focal | + | constitutive | +++ | + het | + het | pos | 474 | 8% | Deserted |
7 | 44 | No | IVB | pT1bNxM1 | 14 | 40 | Present | + | constitutive | neg | ± | pos | 363 | 6% | Tex-acute | |
8 | 40 | No | IIIB | pT3bN0Mx | 4 | 30 | Present | ± | constitutive | +++ | +het | + | pos | 481 | 8% | Deserted |
9 | 47 | No | IB | pT1bN0Mx | 9 | 35 | Focal | +++ | constitutive | + | + het | neg | pos weak | 593 | 14% | Deserted |
10 | 62 | Yes | IB | pT1bN0Mx | 8 | 25 | Focal | +++ | induced | +++ | +/− het | + | pos weak | 1780 | 38% | Tex-acute |
11 | 61 | Yes | IIB | pT2bNxMx | 13 | 25 | Focal | +++ | constitutive | neg | + | + | pos | 1644 | 44% | Deserted |
12 | 49 | No | IB | pT1bNxMx | 11 | 25 | Focal | + focal | induced | neg | +++ | ± | neg | 2890 | 54% | Deserted |
13 | 59 | Yes | IB | pT1bNxMx | 7 | 13 | Focal | ++ het | induced | neg | +++ | ++ | pos weak | 3533 | 93% | Tex-acute |
14 | 35 | No | IB | pT1bNxMx | 11 | 50 | Absent | + het | induced | ++ | + | ++ | pos | 2756 | 33% | Tex-mixed |
15 | 57 | Yes | IIIB | pT3bN0Mx | 7 | 20 | Present | + | constitutive | ++ | ++ het | neg | neg | 72 | 2% | Deserted |
16 | 49 | No | IIIC | pT3bN1Mx | 14 | 25 | Present | +++ | induced | neg | − | + | neg | 1631 | 33% | Tex-chronic |
17 | 60 | Yes | IB | pT1bN0Mx | 19 | 11 | Focal | + | induced | neg | − | ++ | pos | 984 | 50% | Tex-mixed |
18 | 71 | Yes | IB | pT1bN0Mx | 9 | 35 | Focal | + | constitutive | + | − | ++ | pos | 645 | 13% | Tex-mixed |
19 | 51 | Yes | IIIC | pT3bN1Mx | 19 | 60 | Present | +++ | constitutive | + | +/− het | ++het | neg | 1296 | 27% | Tex-chronic |
20 | 69 | Yes | IB | pT1bNxMx | 10 | 40 | Present | ± | induced | ++ | − | ++ | pos het | 666 | 21% | Deserted |
21 | 34 | No | IB | pT1bN0Mx | 3 | 10 | Absent | ++ het | constitutive | +++ | − | ++ | pos | 502 | 10% | Deserted |
NOTE: Abbreviations: FIGO: International Federation of Gynecology and Obstetrics staging system; TMN: standard for classifying the extent of spread of cancer; HPF: high power fields; het: heterogeneous; Total cells/sq mm: total number of cells in the core, based on DAPI staining; Tex: T cell exhausted. The predominant T cell phenotype was defined based on PD1 vs TCF7 expression: High PD1 – low/absent TCF7: acute exhaustion. Low PD1 – TCF7 present: chronic exhaustion. (See supplementary data).